# Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD

Study · id `cardio:ct-nct02798913` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02798913](<https://clinicaltrials.gov/study/NCT02798913>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02798913

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT02798913. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2020-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT02798913, source copy `cardio:ctgov-nct02798913-2019-02-15`, retrieved 2026-10-31)
- Start date: 2016-01 (registry gives no type) (ClinicalTrials.gov record NCT02798913, source copy `cardio:ctgov-nct02798913-2019-02-15`, retrieved 2026-10-31)
- Primary completion: 2020-06 (anticipated) (ClinicalTrials.gov record NCT02798913, source copy `cardio:ctgov-nct02798913-2019-02-15`, retrieved 2026-10-31)
- Completion: 2020-07 (anticipated) (ClinicalTrials.gov record NCT02798913, source copy `cardio:ctgov-nct02798913-2019-02-15`, retrieved 2026-10-31)
- Countries: Italy (ClinicalTrials.gov record NCT02798913, source copy `cardio:ctgov-nct02798913-2019-02-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02798913-2019-02-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD
- Acronym: LONGDAPTPAD
- Condition: Peripheral Artery Disease
- Intervention (Drug): Short DAPT
- Intervention (Drug): Long DAPT
- Lead sponsor: Federico II University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Federico II University (`cardio:org-federico-ii-university`)

## Provenance

Content hash: d25421fa188e0b3b5cdf26a72abc020819b1a658d893f375d06ce13db872f756
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
